300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Costa Rica
China
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Asia
Bermuda
Dominican Republic
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Ames Seed Capital, VC Fund

Ames Seed Capital

VC Fund

Ames, United States

Ames Seed Capital is a pool of private investors.

Total investments:
6
Last investment:
Lead investor:
33%

Last updated:

Industries Ames Seed Capital invests in

PetHealth CareB2BSaaSAgTech

Stages Ames Seed Capital invests in

SeedSeries BSeries CConvertible Note

Countries Ames Seed Capital invests in

United StatesCanada

Round sizes

Seed $100k–$1.2M

Round size

Seed
$100k–$1.2M

Investment Focus

Industry

  • Pet 2 (33%)
  • Health Care 2 (33%)
  • B2B 1 (17%)
  • SaaS 1 (17%)
  • AgTech 1 (17%)
See all 18 industries →

Stage

  • Seed 3 (50%)
  • Series B 1 (17%)
  • Series C 1 (17%)
  • Convertible Note 1 (17%)

Country

  • United States 4 (67%)
  • Canada 1 (17%)

Investments

CompanyDescriptionRoundLinks
VetMeasure VetMeasure
VetMeasure is a developer of a wearable animal health technology harness device designed to remotely monitor health conditions in dogs. The company's device provides accurate detection of an animal's health statistics in real-time, enabling veterinarians and owners to monitor an animal's heart and pulse rates, respiration bodytemperature, and humidity to determine an animal's condition following surgical procedures or illnesses. $100K / Seed / Aug 12, 2019
Pitchly Pitchly
Pitchly provides a SaaS platform for non-technical users to create data-infused real-time PowerPoint and Word documents linked to internal business data wherever it may live. Typically, before Pitchly, this work takes place in disconnected and inefficient tools like Excel, Word, PowerPoint, Sharepoint, or IT-owned databases. The platform aggregatesdisparate information sources, making information easy to catalog, find, and produce compelling and relevant data-driven Word and PowerPoint documents. This generates a 93% reduction in time to create data-heavy documents with 100% error reduction; all in half the time it takes to locate information when compared to traditional approaches.Pitchly end-users can even create custom forms to populate data to those original sources to make certain their teams are using the most relevant and up-to-date data. It aggregates digital data sources, such as Excel, SQL, Salesforce, and more, into one normalized tabular view of the data to reference, search, filter, and then integrate into documents and presentations in real-time. The platform gives the ability to easily publish select information from your database(s) on a website, in various digital forms.The company was founded in 2014 and is headquartered in Des Moines, Iowa. $650K / Convertible Note / Mar 31, 2019
automed automed
A world first, automed is paving the way forward for livestock producers of all sizes. With one single system, you can automatically calculate, deliver and record livestock treatments, and effectively manage your operation. Powerful and easy to use, the automed system integrates easily with existing livestock tools and farm management systems. Theautomed device automatically calculates and delivers both fixed and weight based treatments simply by synchronizing with the automed app. $400K / Seed / Aug 01, 2018
FindBoB FindBoB
FindBoB is a growth, transition and succession planning tool for financial advisors and insurance agents, utilizing machine learning and elements of gamification for asset protection. $1.2M / Seed / Dec 22, 2017
NewLink Genetics NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. $17M / Series C / Jan 31, 2008
NewLink Genetics NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. $8.2M / Series B / Sep 07, 2007

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Costa Rica
China
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Asia
Bermuda
Dominican Republic
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Ames Seed Capital invest in?

Ames Seed Capital invests primarily in Pet, Health Care and B2B startups, most often at Seed and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Ames Seed Capital's check size?

Ames Seed Capital typically joins rounds of $100k–$1.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ames Seed Capital participates in.

When did Ames Seed Capital last invest?

The most recent investment recorded for Ames Seed Capital closed in Aug 2019. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Ames Seed Capital Ames Seed Capital Find emails